172 related articles for article (PubMed ID: 17872346)
1. Clinical and bone density outcomes of tumor-induced osteomalacia after treatment.
Umphrey LG; Whitaker MD; Bosch EP; Cook CB
Endocr Pract; 2007 Sep; 13(5):458-62. PubMed ID: 17872346
[TBL] [Abstract][Full Text] [Related]
2. Persistent tumor-induced osteomalacia confirmed by elevated postoperative levels of serum fibroblast growth factor-23 and 5-year follow-up of bone density changes.
Zimering MB; Caldarella FA; White KE; Econs MJ
Endocr Pract; 2005; 11(2):108-14. PubMed ID: 15901526
[TBL] [Abstract][Full Text] [Related]
3. Tumor-induced osteomalacia: a case report.
Romualdo-Silva DD; Silva BC; Caetano CV; Tibúrcio AM; Nunes MB; Chagas SA; Polito ET; Ferreira AR; Purisch S
Arq Bras Endocrinol Metabol; 2009 Apr; 53(3):378-82. PubMed ID: 19578602
[TBL] [Abstract][Full Text] [Related]
4. A paranasal tumor associated with tumor-induced osteomalacia.
Inokuchi G; Tanimoto H; Ishida H; Sugimoto T; Yamauchi M; Miyauchi A; Nibu K
Laryngoscope; 2006 Oct; 116(10):1930-3. PubMed ID: 17003734
[TBL] [Abstract][Full Text] [Related]
5. Successful CT guided cryoablation of phosphaturic mesenchymal tumor in the soft tissues causing tumor-induced osteomalacia: a case report.
Cowan S; Lozano-Calderon SA; Uppot RN; Sajed D; Huang AJ
Skeletal Radiol; 2017 Feb; 46(2):273-277. PubMed ID: 27921126
[TBL] [Abstract][Full Text] [Related]
6. [Detection of the primary tumor site in tumor-induced osteomalacia by indium-111 octreotide scintigraphy: a case report].
Takahashi M; Toru S; Ota K; Izumiyama H; Yokota T; Mizusawa H
Rinsho Shinkeigaku; 2008 Feb; 48(2):120-4. PubMed ID: 18326305
[TBL] [Abstract][Full Text] [Related]
7. Paraneoplastic Secretion of Multiple Phosphatonins From a Deep Fibrous Histiocytoma Causing Oncogenic Osteomalacia.
Leow MKS; Dogra S; Ge X; Chuah KL; Liew H; Loke KSH; McFarlane C
J Clin Endocrinol Metab; 2021 Apr; 106(5):e2299-e2308. PubMed ID: 33462615
[TBL] [Abstract][Full Text] [Related]
8. A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia.
Arai R; Onodera T; Terkawi MA; Mitsuhashi T; Kondo E; Iwasaki N
BMC Musculoskelet Disord; 2017 Feb; 18(1):79. PubMed ID: 28193220
[TBL] [Abstract][Full Text] [Related]
9. Treatment and outcomes of tumor-induced osteomalacia associated with phosphaturic mesenchymal tumors: retrospective review of 12 patients.
Zuo QY; Wang H; Li W; Niu XH; Huang YH; Chen J; You YH; Liu BY; Cui AM; Deng W
BMC Musculoskelet Disord; 2017 Sep; 18(1):403. PubMed ID: 28934935
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of tumor-induced osteomalacia causing by phosphaturic mesenchymal tumor of the foot.
Liu S; Zhou X; Song A; Huo Z; Wang Y; Xia W; Liu Y
Medicine (Baltimore); 2019 Jul; 98(27):e16296. PubMed ID: 31277164
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic osteomalacia caused by a phosphaturic mesenchymal tumor of the thoracic spine.
Pirola E; Vergani F; Casiraghi P; Leone EB; Guerra P; Sganzerla EP
J Neurosurg Spine; 2009 Apr; 10(4):329-33. PubMed ID: 19441990
[TBL] [Abstract][Full Text] [Related]
12. Pathologic quiz case. A 36-year-old woman with muscle pain and weakness. Phosphaturic mesenchymal tumor (mixed connective tissue variant)/oncogenic osteomalacia.
Reis-Filho JS; Paiva ME; Lopes JM
Arch Pathol Lab Med; 2002 Oct; 126(10):1245-6. PubMed ID: 12385334
[No Abstract] [Full Text] [Related]
13. Tumor-induced osteomalacia associated with a maxillofacial tumor producing fibroblast growth factor 23: report of a case and review of the literature.
Mori Y; Ogasawara T; Motoi T; Shimizu Y; Chikazu D; Tamura K; Fukumoto S; Takato T
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):e57-63. PubMed ID: 20219587
[TBL] [Abstract][Full Text] [Related]
14. A nonphosphaturic mesenchymal tumor mixed connective tissue variant of the sacrum.
Mavrogenis AF; Sakellariou VI; Soultanis K; Mahera H; Korres DS; Papagelopoulos PJ
Orthopedics; 2010 Nov; 33(11):851. PubMed ID: 21053876
[TBL] [Abstract][Full Text] [Related]
15. Tumor-induced osteomalacia - a mystery illness beyond aches, pains, and depression.
Ni HJ; Clifton-Bligh R; Brzozowska MM
Endocr Regul; 2021 Sep; 55(3):163-168. PubMed ID: 34523297
[No Abstract] [Full Text] [Related]
16. Hypercalcemic hyperparathyroidism complicating oncogenic osteomalacia. Effect of successful tumor resection on mineral homeostasis.
Reid IR; Teitelbaum SL; Dusso A; Whyte MP
Am J Med; 1987 Aug; 83(2):350-4. PubMed ID: 3303928
[TBL] [Abstract][Full Text] [Related]
17. [Clinical and immunohistopathologic study of phosphaturic mesenchymal tumor].
Li DM; Wu HW; Li JD; Xia WB; Jiang Y; Zhong DR
Zhonghua Bing Li Xue Za Zhi; 2018 Jun; 47(6):427-431. PubMed ID: 29886586
[No Abstract] [Full Text] [Related]
18. The phosphaturic mesenchymal tumor: why is definitive diagnosis and curative surgery often delayed?
Ledford CK; Zelenski NA; Cardona DM; Brigman BE; Eward WC
Clin Orthop Relat Res; 2013 Nov; 471(11):3618-25. PubMed ID: 23868423
[TBL] [Abstract][Full Text] [Related]
19. Tumor-induced osteomalacia: experience from a South American academic center.
González G; Baudrand R; Sepúlveda MF; Vucetich N; Guarda FJ; Villanueva P; Contreras O; Villa A; Salech F; Toro L; Michea L; Florenzano P
Osteoporos Int; 2017 Jul; 28(7):2187-2193. PubMed ID: 28341900
[TBL] [Abstract][Full Text] [Related]
20. Tumor-induced osteomalacia masking primary hyperparathyroidism.
Elfenbein DM; Weber TJ; Scheri RP
Surgery; 2012 Dec; 152(6):1256-8. PubMed ID: 23158192
[No Abstract] [Full Text] [Related]
[Next] [New Search]
